96 related articles for article (PubMed ID: 6227154)
1. [Role of microcirculatory pathology and chalone regulation of epidermal cell proliferation in the pathogenesis of psoriasis].
Dosychev EA; Eletskaia LV; Moshkalova IA; Topol'nitskiĭ NF; Tret'iakova NN
Vestn Dermatol Venerol; 1983 Aug; (8):13-6. PubMed ID: 6227154
[No Abstract] [Full Text] [Related]
2. [Effect of hemosorption on the anti-chalone properties of the blood serum of patients with psoriasis].
Khvatov EV; Ketlinskiĭ SA; Tret'iakova NN; Simbirtsev AS; Shostka GD
Vestn Dermatol Venerol; 1988; (4):10-2. PubMed ID: 2970719
[No Abstract] [Full Text] [Related]
3. [The beta-blocker effect of the blood serum in patients with psoriasis].
Sokolovskiĭ EV; Raznatovskiĭ IM; Tret'iakova NN
Vestn Dermatol Venerol; 1989; (7):6-7. PubMed ID: 2573218
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell growth inhibiting factors, epidermal chalone and interferon, on the proliferation of epidermal cells.
Kariniemi AL
Acta Derm Venereol Suppl (Stockh); 1977; 57(78):1-26. PubMed ID: 144394
[No Abstract] [Full Text] [Related]
5. [Blockade of adrenoreceptors--a mechanism for impairing the humoral and cellular regulation of the proliferation of epidermal cells in psoriasis].
Raznatovskiĭ IM; Khvatov EV; Egorov VIa
Biull Eksp Biol Med; 1988 Apr; 105(4):488-91. PubMed ID: 2965923
[No Abstract] [Full Text] [Related]
6. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903
[TBL] [Abstract][Full Text] [Related]
7. [Epidermic and lymphocytary chalone receptors in psoriasis].
Vignale RA; Lasalvia E; Espasandin J; Borras A
Med Cutan Ibero Lat Am; 1983; 11(4):233-40. PubMed ID: 6314069
[TBL] [Abstract][Full Text] [Related]
8. [Epidermopoietin--a hypothetical psoriatogenic factor].
Twardowski Z
Przegl Dermatol; 1979; 66(1):103-8. PubMed ID: 154691
[No Abstract] [Full Text] [Related]
9. [Pathogenesis of skin eruptions in psoriasis].
Raznatovskiĭ IM; Tret'iakova NN; Khvatov EV
Vestn Dermatol Venerol; 1988; (9):9-11. PubMed ID: 2975104
[No Abstract] [Full Text] [Related]
10. Chalone-induced inhibition in DNA synthesis of human psoriatic epidermal cells cultured in diffusion chambers in mice.
Kariniemi AL
Ann Clin Res; 1976 Oct; 8(5):340-5. PubMed ID: 136922
[TBL] [Abstract][Full Text] [Related]
11. A cell culture model for the study of epidermal (chalone) homeostasis.
Prunieras M; Delescluse C; Regnier M
Pharmacol Ther; 1980; 9(3):271-95. PubMed ID: 6447881
[No Abstract] [Full Text] [Related]
12. [Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris].
Braun-Falco O
Hautarzt; 1976 Aug; 27(8):363-4. PubMed ID: 182658
[TBL] [Abstract][Full Text] [Related]
13. [Biological activity of epidermal chalones in the presence of blood serum from patients with psoriasis].
Tret'iakova NN
Biull Eksp Biol Med; 1984 Jun; 97(6):754-5. PubMed ID: 6234950
[TBL] [Abstract][Full Text] [Related]
14. Lack of relationship between Langerhans cells, epidermal cell proliferation and epidermal G1 chalone.
Schweizer J; Marks F
Experientia; 1978 Sep; 34(9):1235-7. PubMed ID: 152716
[TBL] [Abstract][Full Text] [Related]
15. [Modifying effect of the blood serum of patients with psoriasis on the inhibitory activity of epidermal chalones].
Dosychev EA; Ketlinskiĭ SA; Tret'iakova NN
Vestn Dermatol Venerol; 1981 Mar; (3):18-20. PubMed ID: 6455018
[No Abstract] [Full Text] [Related]
16. [Immunomorphological analysis of G2-chalone localization during the process of rat epidermis histogenesis].
Simbirtsev AS; Dyban PA
Biull Eksp Biol Med; 1982 Jun; 93(6):106-7. PubMed ID: 6214289
[TBL] [Abstract][Full Text] [Related]
17. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism?
Voorhees JJ; Duell EA
Arch Dermatol; 1971 Oct; 104(4):352-8. PubMed ID: 4329804
[No Abstract] [Full Text] [Related]
18. [Suppression of epidermal cellular proliferation of normal human skin under exposure to epidermal chalones in vitro].
Dosychev EA; Topol'nitskiĭ NF; Ketlinskiĭ SA
Vestn Dermatol Venerol; 1980 Feb; (2):4-8. PubMed ID: 6444478
[No Abstract] [Full Text] [Related]
19. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.
Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014
[TBL] [Abstract][Full Text] [Related]
20. Disturbance by tumor promotors of epidermal growth control (chalone mechanism).
Marks F; Grimm W; Krieg L
Hoppe Seylers Z Physiol Chem; 1972 Dec; 353(12):1970-2. PubMed ID: 4346531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
